| 1. |
姚一菲, 孫可欣, 鄭榮壽. 《2022全球癌癥統計報告》解讀: 中國與全球對比. 中國普外基礎與臨床雜志, 2024, 31(7): 769-780.
|
| 2. |
中華醫學會內分泌學分會, 中華醫學會外科學分會甲狀腺及代謝外科學組, 中國抗癌協會頭頸腫瘤專業委員會, 等. 甲狀腺結節和分化型甲狀腺癌診治指南(第二版). 中華內分泌代謝雜志, 2023, 39(3): 181-226.
|
| 3. |
何林燁, 王藝超, 李志輝. 2022年中國甲狀腺癌流行情況分析: 基于《中國腫瘤登記年報》2005–2018年數據. 中國普外基礎與臨床雜志, 2024, 31(7): 790-795.
|
| 4. |
Wang Z, Gui Z, Wang Z, et al. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis. Clin Endocrinol (Oxf), 2023, 98(4): 609-621.
|
| 5. |
Lou J, Yang J, Luo Y, et al. Analysis of the influence factors of cervical lymph node metastasis in papillary thyroid carcinoma: A retrospective observational study. Medicine (Baltimore), 2023, 102(36): e35045. doi: 10.1097/MD.0000000000035045.
|
| 6. |
Cai H, Zhuge L, Huang Z, et al. Distinct risk factors of lateral lymph node metastasis in patients with papillary thyroid cancer based on age stratification. BMC Surg, 2024, 24(1): 24. doi: 10.1186/s12893-024-02309-2.
|
| 7. |
Du J, Yang Q, Sun Y, et al. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study. Front Endocrinol (Lausanne), 2023, 14: 1288527. doi: 10.3389/fendo.2023.1288527.
|
| 8. |
Shao L, Wang Z, Dong W, et al. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma. Cancer Med, 2023, 12(22): 20670-20676.
|
| 9. |
Huang W, Chen D, Zhong M, et al. Factors of central lymph node metastasis in papillary thyroid cancer based on C-TIRADS analysis. Horm Metab Res, 2023, 55(9): 585-591.
|
| 10. |
Liu J, Guo M. Clinical analysis of cervical lymph node metastasis patterns and multivariate factors in differentiated thyroid carcinoma. Oncol Lett, 2023, 26(4): 431. doi: 10.3892/ol.2023.14018.
|
| 11. |
Muhanhali D, Deng L, Ai Z, et al. Impaired thyroid hormone sensitivity increases the risk of papillary thyroid cancer and cervical lymph node metastasis. Endocrine, 2024, 83(3): 659-670.
|
| 12. |
Chang L, Zhang Y, Zhu J, et al. An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study. Front Endocrinol (Lausanne), 2023, 14: 964074. doi: 10.3389/fendo.2023.964074.
|
| 13. |
Lim ST, Jeon YW, Suh YJ. Correlation between surgical extent and prognosis in node-negative, early-stage papillary thyroid carcinoma originating in the isthmus. World J Surg, 2016, 40(2): 344-349.
|
| 14. |
American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid, 2009, 19(11): 1153-1158.
|
| 15. |
Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules—2016 update appendix. Endocr Pract, 2016, 22(5): 622-639.
|
| 16. |
Jiwang L, Jinghui B, Fengqin F, et al. Comprehensive analysis of clinicopathologic and sonographic features in thyroid cancer with skip lymph node metastasis: establish and assessment of a prediction nomogram. Braz J Otorhinolaryngol, 2023, 89(5): 101301. doi: 10.1016/j.bjorl.2023.101301.
|
| 17. |
Wu WX, Qi GF, Feng JW, et al. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification. Eur Arch Otorhinolaryngol, 2023, 280(5): 2511-2523.
|
| 18. |
Guo P, Wang X, Xia L, et al. Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model. Cancer Med, 2023, 12(7): 7868-7876.
|
| 19. |
康韶洋, 胡曉東, 聶智梅, 等. 甲狀腺乳頭狀癌頸部淋巴結轉移的危險因素分析—單中心回顧性研究. 解放軍醫學雜志, 2023, 48(5): 510-515.
|
| 20. |
Kim BY, Choi N, Kim SW, et al. Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma. Eur Arch Otorhinolaryngol, 2020, 277(2): 569-576.
|
| 21. |
劉曉楠, 邸旭, 張強, 等. 低風險甲狀腺微小乳頭狀癌的診治進展. 中國實用外科雜志, 2023, 43(2): 231-234.
|
| 22. |
Abood A, Ovesen T, Rolighed L, et al. Hypoparathyroidism following total thyroidectomy: high rates at a low-volume, non-parathyroid institution. Front Endocrinol (Lausanne), 2024, 15: 1330524. doi: 10.3389/fendo.2024.1330524.
|
| 23. |
Best CAE, Hussain J, Johnson-Obaseki S. Alternative sources of cautery in thyroid surgery and the risk of recurrent laryngeal nerve injury: A retrospective, risk-adjusted analysis from the national surgical quality improvement program. J Otolaryngol Head Neck Surg, 2024, 53: 19160216241265687. doi: 10.1177/19160216241265687.
|
| 24. |
Hassan I, Hassan L, Bacha F, et al. Clinico-pathological initial outcome of a newly adopted novel surgical technique for nodal metastatic thyroid cancer at a large-volume centre in a high-income developing country. Front Surg, 2023, 10: 1204230. doi: 10.3389/fsurg.2023.1204230.
|
| 25. |
Santamaria-Barria JA, Graff-Baker AN, Chang SC, et al. Disparities in the impact of the AJCC 8th edition staging system on differentiated thyroid cancer outcomes. Head Neck, 2022, 44(10): 2129-2141.
|
| 26. |
Qi GF, Feng JW, Wu WX, et al. Construction of a nomogram for central lymph node metastasis in papillary thyroid cancer based on gender grouping. Eur Arch Otorhinolaryngol, 2024, 281(2): 965-975.
|
| 27. |
Liu W, Zhang D, Jiang H, et al. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study. Front Endocrinol (Lausanne), 2023, 14: 1233929. doi: 10.3389/fendo.2023.1233929.
|
| 28. |
Kwon O, Lee S, Bae JS. Risk factors associated with high-risk nodal disease in patients considered for active surveillance of papillary thyroid microcarcinoma without extrathyroidal extension. Gland Surg, 2023, 12(9): 1179-1190.
|
| 29. |
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid, 2014, 24(1): 27-34.
|
| 30. |
Nguyen BQ, Vu HT, Nguyen LMT, et al. Clinicopathologic characteristics of thyroid microcarcinoma: Findings from a hospital-based study in Vietnam. Discov Med, 2024, 36(180): 209-216.
|
| 31. |
Ngo DQ, Le DT, Ngo QX, et al. Risk factors for lateral lymph node metastasis of papillary thyroid carcinoma in children. J Pediatr Surg, 2022, 57(10): 421-424.
|
| 32. |
Liu W, Wang S, Xia X, et al. A proposed heterogeneous ensemble algorithm model for predicting central lymph node metastasis in papillary thyroid cancer. Int J Gen Med, 2022, 15: 4717-4732.
|
| 33. |
Jin L, Zheng D, Mo D, et al. Glucose-to-lymphocyte Ratio (GLR) as a predictor of preoperative central lymph node metastasis in papillary thyroid cancer patients with type 2 diabetes mellitus and construction of the nomogram. Front Endocrinol (Lausanne), 2022, 13: 829009. doi: 10.3389/fendo.2022.829009.
|
| 34. |
Zhang T, He L, Wang Z, et al. Risk factors of cervical lymph node metastasis in multifocal papillary thyroid cancer. Front Oncol, 2022, 12: 1003336. doi: 10.3389/fonc.2022.1003336.
|
| 35. |
Zheng H, Lai V, Lu J, et al. Clinical factors predictive of lymph node metastasis in thyroid cancer patients: a multivariate analysis. J Am Coll Surg, 2022, 234(4): 691-700.
|
| 36. |
Elbasan O, Ilg?n C, Gogas Yavuz D. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?. Endokrynol Pol, 2023, 74(2): 153-167.
|
| 37. |
Han Y, Hou L, Zhao B, et al. Risk factors for neck nodal metastasis in papillary thyroid cancer with BRAFV600E mutation. Front Endocrinol (Lausanne), 2022, 13: 884428. doi: 10.3389/fendo.2022.884428.
|
| 38. |
Feng JW, Wu WX, Qi GF, et al. Nomograms based on sonographic and clinicopathological characteristics to predict lateral lymph node metastasis in classic papillary thyroid carcinoma. J Endocrinol Invest, 2022, 45(11): 2043-2057.
|
| 39. |
Cui L, Feng D, Zhu C, et al. Clinical outcomes of multifocal papillary thyroid cancer: A systematic review and meta-analysis. Laryngoscope Investig Otolaryngol, 2022, 7(4): 1224-1234.
|
| 40. |
Wei B, Yao J, Peng C, et al. Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma. BMC Cancer, 2023, 23(1): 1225. doi: 10.1186/s12885-023-11721-5.
|
| 41. |
Ozdemir K, Harmantepe AT, Gonullu E, et al. Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer?. Updates Surg, 2023, 75(3): 701-706.
|
| 42. |
Ye L, Hu L, Liu W, et al. Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: A retrospective study. BMC Cancer, 2021, 21(1): 1250. doi: 10.1186/s12885-021-08875-5.
|
| 43. |
Sun W, Zheng B, Wang Z, et al. Meta-analysis of risk factors for CCLNM in patients with unilateral cN0 PTC. Endocr Connect, 2020, 9(5): 387-395.
|
| 44. |
Guo K, Qian K, Shi Y, et al. Clinical and molecular characterizations of papillary thyroid cancer in children and young adults: A multicenter retrospective study. Thyroid, 2021, 31(11): 1693-1706.
|
| 45. |
Dong Y, Wang D, Luo Y, et al. Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma. Oncol Lett, 2021, 21(3): 188. doi: 10.3892/ol.2021.12449.
|
| 46. |
Shi P, Yang D, Liu Y, et al. A protective factor against lymph node metastasis of papillary thyroid cancer: Female gender. Auris Nasus Larynx, 2023, 50(3): 440-449.
|
| 47. |
Li R, Hao J, Zhu Z, et al. Correlation between US-FNAC with BRAFV600E mutation analysis and central neck lymph node metastasis in cN0 papillary thyroid cancer. Biomed Res Int, 2021, 2021: 9937742. doi: 10.1155/2021/9937742.
|